Business Description
Swedish Orphan Biovitrum AB
ISIN : SE0000872095
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.05 | |||||
Equity-to-Asset | 0.5 | |||||
Debt-to-Equity | 0.47 | |||||
Debt-to-EBITDA | 2.2 | |||||
Interest Coverage | 2.81 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.52 | |||||
Beneish M-Score | -2.57 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.5 | |||||
3-Year EBITDA Growth Rate | 1.1 | |||||
3-Year EPS without NRI Growth Rate | -2.5 | |||||
3-Year Book Growth Rate | 15.1 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 35.66 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 12.49 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 37.68 | |||||
9-Day RSI | 47.19 | |||||
14-Day RSI | 52.26 | |||||
6-1 Month Momentum % | 20.88 | |||||
12-1 Month Momentum % | 44.04 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.73 | |||||
Quick Ratio | 0.49 | |||||
Cash Ratio | 0.05 | |||||
Days Inventory | 258.72 | |||||
Days Sales Outstanding | 74.51 | |||||
Days Payable | 63.94 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.2 | |||||
Shareholder Yield % | -10.79 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 77.19 | |||||
Operating Margin % | 17.71 | |||||
Net Margin % | 9.04 | |||||
FCF Margin % | 21.38 | |||||
ROE % | 6.35 | |||||
ROA % | 2.87 | |||||
ROIC % | 4.37 | |||||
3-Year ROIIC % | -0.09 | |||||
ROC (Joel Greenblatt) % | 958.45 | |||||
ROCE % | 7.07 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 49.2 | |||||
Forward PE Ratio | 21.87 | |||||
PE Ratio without NRI | 43.71 | |||||
Shiller PE Ratio | 40.4 | |||||
Price-to-Owner-Earnings | 24.98 | |||||
PEG Ratio | 5.75 | |||||
PS Ratio | 4.46 | |||||
PB Ratio | 2.91 | |||||
Price-to-Free-Cash-Flow | 20.94 | |||||
Price-to-Operating-Cash-Flow | 15.75 | |||||
EV-to-EBIT | 29.86 | |||||
EV-to-Forward-EBIT | 18.43 | |||||
EV-to-EBITDA | 15.68 | |||||
EV-to-Forward-EBITDA | 11.83 | |||||
EV-to-Revenue | 5.14 | |||||
EV-to-Forward-Revenue | 4.46 | |||||
EV-to-FCF | 24.12 | |||||
Price-to-Projected-FCF | 2.31 | |||||
Price-to-DCF (Earnings Based) | 2.96 | |||||
Price-to-DCF (FCF Based) | 1.42 | |||||
Price-to-Median-PS-Value | 0.92 | |||||
Earnings Yield (Greenblatt) % | 3.35 | |||||
FCF Yield % | 4.79 | |||||
Forward Rate of Return (Yacktman) % | 6.98 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Swedish Orphan Biovitrum AB Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 2,083.496 | ||
EPS (TTM) (€) | 0.557 | ||
Beta | 0.37 | ||
Volatility % | 29.64 | ||
14-Day RSI | 52.26 | ||
14-Day ATR (€) | 0.471457 | ||
20-Day SMA (€) | 28.207 | ||
12-1 Month Momentum % | 44.04 | ||
52-Week Range (€) | 17.56 - 29.6 | ||
Shares Outstanding (Mil) | 341.79 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Swedish Orphan Biovitrum AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Swedish Orphan Biovitrum AB Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Swedish Orphan Biovitrum AB Frequently Asked Questions
What is Swedish Orphan Biovitrum AB(FRA:B6E)'s stock price today?
When is next earnings date of Swedish Orphan Biovitrum AB(FRA:B6E)?
Does Swedish Orphan Biovitrum AB(FRA:B6E) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |